The association of pityriasis rosea with cytomegalovirus, Epstein-Barr virus and parvovirus B19 infections - A prospective case control study by polymerase chain reaction and serology

European Journal of Dermatology

Volumn 13, Issue 1, 2003, Pages 25-28

  Chuh, Antonio A T ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Bonham Surgery   (Hong Kong)

Author keywords

Erythema infectiosum; Human herpesvirus 6; Human herpesvirus 7; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; MALE; PARVOVIRUS; PITYRIASIS ROSEA; POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEROLOGY; SEROPREVALENCE; VIRUS DETECTION; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHILD; CROSS REACTIONS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PITYRIASIS ROSEA; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SEROLOGIC TESTS;

EID: 0037283172     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Chuang TY, Perry HO, Ilstrup DM, Kurland LT. Recent upper respiratory tract infection and pityriasis rosea: a case-control study of 249 matched pairs. Br J Dermatol 1983; 108: 587-591.
2. Traore A, Korsaga-Some N, Niamba P et al. Pityriasis rosea in secondary schools in Ouagadougou, Burkina Faso. Ann Dermatol Venereol 2001; 128: 605-609.
3. Vigh G. Observations on pityriasis rosea patients. Z Hautkr 1983; 58: 1268-1272.
4. Messenger AG, Knox EG, Summerly R et al. Case clustering in pityriasis rosea: support for role of an infective agent. Br Med J (Clin Res Ed) 1982; 284: 371-373.
5. Drago F, Ranieri E, Malaguti F et al. Human herpesvirus 7 in pityriasis rosea. Lancet 1997; 349: 1367-1368.
6. Drago F, Ranieri E, Malaguti F et al. Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin. Dermatology 1997; 195: 374-378.
7. Watanabe T, Sugaya M, Nakamura K, Tamaki K. Human herpesvirus 7 and pityriasis rosea. J Invest Dermatol 1999; 113: 288-289.
8. Kempf W, Adams V, Kleinhans M et al. Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol 1999; 135: 1070-1072.
9. Yoshida M. Detection of human herpesvirus 7 in patients with pityriasis rosea and healthy individuals. Dermatology 1999; 199: 197-198.
10. Kosuge H, Tonaka-Tayo K, Miyoshi H et al. Epidemiological study of human herpesvirus-6 and human herpesvirus-7 in pityriasis rosea. Br J Dermatol 2000; 143: 795-879.
11. Offidani A, Pritelli E, Simonetti O et al. Pityriasis rosea associated with herpesvirus 7 DNA. J Eur Acad Dermatol Venereol 2000; 14: 313-314.
12. Wong WR, Tsai CY, Shih SR, Chan HL. Association of pityriasis rosea with human herpesvirus-6 and human herpesvirus-7 in Toipei. J Formos Med Assoc 2001; 100: 478-483.
13. Chuh AA, Chiu SS, Peiris JS. Human herpesvirus 6 and 7 DNA in peripheral blood leucocytes and plasma in patients with pityriasis rosea by polymerase chain reaction: a prospective case control study. Acta Derm Venereol 2001; 81: 289-290.
14. Watanabe T, Kawamura T, Jacob SE et al. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. J Invest Dermatol 2002; 119: 793-797.
15. Chuh AA, Chan HH. Prospective case-control study of chlamydia, legionella and mycoplasma infections in patients with pityriasis rosea. Eur J Dermatol 2002; 12: 170-173.
16. Chuh AA, Au TS. Pityriasis rosea - a review of the specific treatments. Proc R Coll Physicians Edinb 2001; 31: 203-207.
17. Kashiwagi Y, Nemoto S Hisashi et al. Cytomegalovirus DNA among children attending two day-care centers in Tokyo. Pediatr Int 2001; 43: 493-495.
18. Bonafe JL, Icart J, Perpere M, et al. Histopathologic, ultrastructural, immunologic and virologic study of Gibert's pityriasis rosea. Ann Dermatol Venereol 1982; 109: 855-861.
19. Grilli R, Izquierdo MJ, Farina MC et al. Papular-purpuric "gloves and socks" syndrome: polymerose chain reaction demonstration of parvovirus B19 DNA in cutaneous lesions and sera. J Am Acad Dermatol 1999; 41: 793-796.
20. Passoni LF, Ribeiro SR, Giordani ML et al. Papular-purpuric "gloves and socks" syndrome due to parvovirus B19: report of a case with unusual features. Rev Inst Med Trop Sao Paulo 2001; 43: 167-170.
21. Tonelli S, Luppi M, Morselli M et al. "Gloves and socks" papular purpuric syndrome following primary infection with parvovirus B19: A link between dermatologists and haematologists. Br J Haematol 2002; 117: 773-774.
22. Marcus-Farber BS, Bergman R, Ben Porath E et al. Serum antibodies to parvovirus B19 in patients with pityriasis rosea. Dermatology 1997; 194: 371.
23. Sevall JS. Detection of parvovirus B19 by dot-blot and polymerase chain reaction. Mol Cell Probes 1990; 4: 237-246.
24. Koch WC, Adler SP. Detection of human parvovirus B19 DNA by using the polymerase choin reaction. J Clin Microbiol 1990; 28: 65-69.
25. Takeda N, Isonuma H, Sekiya S et al. [Studies of anticytomegalovirus IgG antibody positive rate and cytomegalovirus mononucleosis in adults.] Kansenshogaku Zasshi 2001; 75: 775-779.
26. Pancharoen C, Bhatrarakosol P, Thisyakorn U. Seroprevalence of Epstein-Barr virus infection in Thai children. J Med Assoc Thai 2001; 84: 850-854.
27. Abarca K, Cohen BJ, Vial PA. Seroprevalence of parvovirus B19 in urban Chilean children and young adults, 1990 and 1996. Epidemiol Infect 2002; 128: 59-62.
28. Halkier-Sorensen L. Recurrent pityriasis rosea. New episodes every year for five years. A case report. Acta Derm Venereol 1990; 70: 179-180.
29. Bosc F. Is pityriasis rosea infectious? Lancet 1981; 1(8221): 662.
30. Davis SWV. Case clustering in pityriasis rosea: support for role of an infectve agent. Br Med J (Clin Res Ed) 1982; 284: 1478.
31. Bjornberg A, Hellgren L. Pityriasis rosea. A statistical, clinical and laboratory investigation of 826 patients and matched healthy controls. Acta Derm Venereol 1962; 42: 50.
32. Chuang TY, Ilstrup DM, Perry HO, Kurland LT. Pityriasis rosea in Rochester, Minnesota, 1969 to 1978. J Am Acad Dermatol 1982; 7: 80-89.
33. de Souza Sittart JA, Tayah M, Soares Z. Incidence pityriasis rosea of Gibert in the Dermatology Service of the Hospital do Servidor Publico in the state of Sao Paulo. Med Cutan Ibero Lat Am 1984; 12: 336-338.
34. Ahmed MA. Pityriasis rosea in the Sudan. Int J Dermatol 1986; 25: 184-185.
35. Olumide Y. Pityriasis rosea in Lagos. Int J Dermatol 1987; 26: 234-236.
36. Cheong WK, Wong KS. An epidemiological study of pityriasis rosea in Middle Road Hospital. Singapore Med J 1989; 30: 60-62.
37. Harman M, Aytekin S, Akdeniz S, Inaloz HS. An epidemiological study of pityriasis rosea in the Eastern Anatolia. Eur J Epidemiol 1998; 14: 495-497.
38. Sharma PK, Yadav TP, Gautam RK et al. Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial. J Am Acad Dermatol 2000; 42: 241-244.